<SEC-DOCUMENT>0001193125-15-121129.txt : 20150407
<SEC-HEADER>0001193125-15-121129.hdr.sgml : 20150407
<ACCEPTANCE-DATETIME>20150407132106
ACCESSION NUMBER:		0001193125-15-121129
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150406
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150407
DATE AS OF CHANGE:		20150407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		15755802

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		949-260-1200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d905739d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): April&nbsp;6, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN VANGUARD CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-13795</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>95-2588080</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4695 MacArthur Court </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Newport Beach, California 92660 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number: (949)&nbsp;260-1200 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As reported in a press release dated April&nbsp;6, 2015, American Vanguard Corporation
announced that its international subsidiary, AMVAC Netherlands B.V., had acquired the Nemacur nematicide product line in Europe from Adama Agricultural Solutions Ltd. Financial terms of the acquisition were not disclosed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full text of that press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 99.1:&nbsp;&nbsp; Press release dated April&nbsp;6, 2015 of American Vanguard Corporation.
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3">AMERICAN VANGUARD CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: April&nbsp;7, 2015</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Timothy J. Donnelly</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Timothy J. Donnelly</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Chief Administrative Officer, General Counsel</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&amp; Secretary</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX TO EXHIBITS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit&nbsp;99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release of American Vanguard Corporation dated April 6, 2015.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d905739dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g905739g47u66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FOR IMMEDIATE RELEASE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>American Vanguard Acquires Nemacur<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Nematicide Assets in Europe </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Newport Beach, California... April&nbsp;6, 2015 &#150; American Vanguard Corporation (NYSE:AVD), through its international subsidiary AMVAC Netherlands B.V.,
today announced the acquisition of Adama Agricultural Solutions Ltd.&#146;s European Nemacur<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> insecticide/nematicide business assets. Financial terms of the agreement were not disclosed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The assets acquired include all trademarks, product registrations, associated registration data, and customer information that relates to the marketing and
sale of this crop protection product in Europe. Nemacur is a highly effective insecticide/nematicide used to control soil insects and nematodes on many fruit and vegetable crops. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eric Wintemute, Chairman&nbsp;&amp; CEO of American Vanguard commented: &#147;Having previously acquired Nemacur assets outside of Europe from Bayer Crop
Science in 2010, this purchase completes our worldwide ownership of this proven crop protection product. It represents an important addition to our existing insecticide portfolio and will significantly enhance our international expansion
initiative.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ad de Jong, Managing Director of AMVAC Netherlands B.V. and International Marketing and Sales Director commented: &#147;This
acquisition strengthens considerably our competitive position in Europe for high value fruit and vegetable crops. We look forward to working with the Adama team that will be appointed as AMVAC&#146;s distributor for Nemacur in Greece, Italy,
Portugal and Spain.&#148; <B> </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About American Vanguard </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and
management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;&amp; Russell
3000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Indexes and the Standard&nbsp;&amp; Poors Small Cap 600 Index. To learn more about American Vanguard, please reference the Company&#146;s web site at <U>www.american-vanguard.com</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In its public commentary, the Company may discuss forward-looking information. Except for the historical information contained in this release, all
forward-looking statements are estimates by the Company&#146;s management subject to various risks and uncertainties that may cause results to differ from management&#146;s current expectations. Such factors include weather conditions, changes in
regulatory policy and other risks as detailed in the Company&#146;s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company&#146;s judgment as of the date of this release. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact Information</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Vanguard
Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">William A. Kuser, Director of Investor Relations</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(949) 260-1200</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">williamk@amvac-chemical.com</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Equity Group Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lena Cati</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212) 836-9611 / Lcati@equityny.com</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">www.theequitygroup.com</P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g905739g47u66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g905739g47u66.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`"\`T0,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`-'Q_K&IVFH3+;ZE<PKG@)*17U>`P]*5-.44>#B*LU4LF>:3
M^*_$<9.W7M07'_3PW^->G]3P[^PC:%236Y[1\$M4U'5?#^HRZA?3W;I<A5:9
MRQ`VC@9KYK.*4*56*@K:'?AY-IW/3R2.WY5XYT7L()$)QG!]#19BYD/I%!0`
M4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`'@GQ#AEDU&<QQ.
MX!YVJ37V.7R4::NSYS$)^T.<\)V%FGB"Y>^M(KF.PM);JX$J[E!5?E7'KDC-
M7C*DW37([7:2.R@EU.^^"^JV]EX3U6^U.[AMHC>@&25@B@E0`/05XV<KEJQ7
MD=V'V9Z18>*_#^JW45K8:S97,\JETCBF5F8#J0*\0Z18_$.@WLMY##JEI+)9
M`M<*DH)B`ZD^@%--K83BGN4/^$GM#=V$.FW$>H17DDD:R0RJRHR+N(/.3QZ9
MJURRW,VI1V+=CXLT._FN(8=4M6FM<^>@E!\O'7/I2<&MBHSOOH2V_B?0KJP>
M^@UBSDM(W$;S+,NQ6/0$YXJ"RWIVJ6&KVOVK3KR&[@W%?,A<.N1U&10!0N_$
MUC8Z^=(N5DCE^QO>"0@;&13A@#GJ.#]*`(].\8:+?V>FSO>1V<FHQB2WM[EU
M25U/0[<]Z`+PU[2#J*Z<-3M#>DE1;^<OF$CJ-N<YH`$UW29+][!-3M&O$;8T
M`F4N#C.-N<YQ0!+%J=A-Y7E7L#^<K/'MD!WJO4CU`[T`0P:_HUS;2W,&JV<L
M$+!))$G4JA/`!.>*`*6L>,M"T32FU&YU&!XO*,L:12*SRJ.I09^;\*`-N*02
MQ)(N=KJ&&?>@#E+SXBZ19:I<6AMK^6WM9EM[F]BMRT$$AQ\K-U[C.`<9H`Z*
M35]-BU"/3Y+^V2]D&Y(&E42,/4+G)H`:VM:4DDL;:E:J\(S*IF7,?./FYXY.
M.:`%AUC3+BSEO(=1M9+6$D23),I1".N3G`H`:-;TIK%+X:G:&TD.$G\Y=C'T
M#9QV-`"G6M+6[@M#J-J+F=0T41F7>X/0@9R10!E)XWT6>.Y:TF:Y-K>K8S+%
MC*2$@`\D?+SU]C0!L?VIIXU'^SOMUO\`;=N[[/YJ^9CUVYS0`V'6-,N+S['!
MJ-K+<X)\E)E+\'!X!SP:`+M`'B7CAGMM2N;UR1';\PKT#2'[OY<D_2OJ,':5
M-06[W]#P:VE1M['*V_GVOPYU_4Y$8WE\\=D#M^9DSO9C^'&:Z:G++%4Z:V6I
MT4G:#9N_#?P_<>)/AO>V,+Q*PU:&9O-'RE4*,1^0KRLZ_CQ]#MP^S.UL_A[=
MVNN6U\'M$6+6;J_8Q@AO*EC*JHXZ@GZ5X9TF9HOPOU73H+NWFFM6V:?<65M,
M)I&+^;T+*1A1ZCGF@#H8/!$MM_PAZV_V:!-&BD6X$0V[V:$)N7CDYYR:`,.P
M^'FMP:#<:6ZZ-$T%C):VUVD1:69F;(:3(X'J.>>:N,W'8F4%+<PO^%?>(-/T
MK4K:Z^RM%>W%I,096E7$1&025'7''&.U;PA&KZF4YNGZ'=>"XHM,U#7VD:&!
M=0OS<0Q+QM78JX],Y4U-3#SAYH(5XRTV'_$#PC>^*;:Q;3+J.VNH7:*1W_B@
MD7;(HQWQC'TKG-S"\5_#_6-6UK?I_P!D2P1+5807\LH(GR0P"DMD=.0!Z4`6
MF\`7AU1[X+9B8^(EU/S/X_("XVYQG/MTH`Y30]+N4\?Z/IT-C'(FGZE=SRW7
MV62.;:X;F1F7;C+`#!.>*`-O1_`GB:R>QAF&FI#IMC>6EO('9S(93E692N`/
M49-`%"W^&&O/HVLVEPEHC7]O9Q!#-N&8I,OG"``$=`!0!I^+_AYJ%]>:D-'T
M_2Y+6^L([2/SSL^Q%&)^0!3P<]L<B@#TZWC,5M%&V,H@4X]A0!P5MH/C#0[S
M4K#1FT_^SK^_:\%[,Q,L`<@NOEXPQX.#GO0!2U7P%J]WXCOFBBL7M;[4(+[^
MT78BYMA'MS&HQS]W`.0,,:`*?B?PC+I?@7QK</902WVIWQG1HD+.\1D0JK8&
M>QXH`=<>!=4N;+5YI;;2].FOKNUE@TV.3,$OD]58[1]_V'89H5WL*]B9?AWJ
M%[:K]NL["*.XUR+49M/C;=#%$J;2HX`8GJ>`.:!AK_@37-0\9KJ%M#9BRBO+
M2>(JXC*QQ8W*5"Y)ZX^8#':@":;P+JS)JMO%#:)'<:_#J<4@?!:,,I92,<$;
M>/K0`UO`>K_\).7$%C]E.L_VK_:>\_:0O_/'&/PSG&.U`#M*^'U[I^J:/?>1
M:+/;ZO=WEQ*A^=HI`VT9QD]1Q[4`>ET`>#_$6]?[5);[5,*DD!AG!/4_6OK\
MNI+D4NI\[B)/GY3RBXE;<?G;'3K7L<J.BFCWKX"_\B??'_I\/_H*U\GG?\=>
MAZ.'V9ZM7B'2%`!0`E``RAE*L`0>H-&P&#J7AQ)LR6A$;?W#T/\`A7;1Q;CI
M/8Y*F'3U@8,>JZIH<ODR@E%_Y9R]/P-=KH4<0KQ.55:E%V9OV'BO3[O"3/\`
M9I3VDZ'\:X:N#J0U6J.NGBH3T>C-Q6#*&4@J>A%<>QU+4=0`4`%`!0`4`%`!
M0!@:OXF2TO5TO38#J&KN,BW0X6(?WI&_A'ZGM713P[DN>;M'O_D9RJ6TCJR?
M2]&D@F^W:G<?;-188WXPD0_NQKV'OU/>IJ5$URP5E_6X0A;66K-BL30*`"@`
MH`*`"@#D=8^'6BZW,TMTURK-UV28_I7I4<RK45RQL<4\%3D[G/R_`WPO(3_I
M&H#Z2K_A6_\`;6([(M8:*V9UOA'PA8>#-,EL-/EFDBDE,I,Q!.<`=@/2O/Q.
M)GB9\\S>$%#8Z&N8L*`"@`H`*`"@""ZL[>\B,5Q"LB>A'2JA.4'>+)E%25F<
MEJO@MMK/I[AA_P`\Y#S^!KU*.86TJ'!5P?6!S?VS6?#\WEI)-;D?P/RI_`\5
MZ'LZ&)5]&<2G5HNQL6?Q&>/"ZA9`CN\+<_D:Y*F5=:<OO.F&8=)HW[/QMH%X
M0HOUA<_PS#8?\*X:F`Q%/>)UPQ=&74V8;VVN`#!<Q2C_`&'!KD<)1W1T*47L
MRQ4E$4MQ#;KNFF2-?5V`_G346]D)R2W.9U;XC^%M'#"75(YY%_Y9V_[QOTX_
M6NVEE^)J[1LO,QEB*<>IC6^L>*_&^!IENV@Z,W6[E&9Y!_L#H/K71*CAL)\;
MYY=EM\S-3J5OAT1U^A>']/\`#UF;:PA(+G=+*YW22M_>9NI->?6K3K.\CHA!
M06AJUB6%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!%/;07,9CGA25/
M1US51DXNZ=B914E9HYF_\`Z3=Y,)DMF/]PY'Y&N^EF5:&^IQSP-*6VAR]]\,
MM1`/V6Z@F'8-E"?YBO2IYO3^U&QQ3RZ:^%W,"?X?^(X#\ELF1W2=1_6NM9EA
M9+7\CG>#KQV_,CC\!>,)_D1G0>]Y_@:3S#!1UM^!4<-B+_\`!+]K\&M5O&!U
M35TB7N$W2-^N!7//.*4=*4#JA@:C^-G;>'_AGX;\/NLR6GVNY7D2W/S8/L.@
HKRL1F.(KZ-V7D=U/#0AYG8````"O/.D6@`H`*`"@`H`*`"@`H`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
